Telomerase as tumor marker

被引:148
作者
Hiyama, E
Hiyama, K
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Gen Med, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Translat Canc Res, Minami Ku, Hiroshima 7348551, Japan
关键词
telomerase; human telomerase reverse transcriptase; human telomerase RNA component; biopsy; fine needle aspiration; cytology; telomeric repeat amplification protocol; diagnosis; prognosis; immunohistochemistry; tumor; cancer;
D O I
10.1016/S0304-3835(02)00709-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomerase, a critical enzyme responsible for continuous cell growth, is repressed in most somatic cells except proliferating progenitor cells and activated lymphocytes, and activated in approximately 85% of human cancer tissues. Telomerase activity is a useful cancer-cell detecting marker in some types of cancers in which almost all cases show telomerase activation. In other types in which telomerase becomes upregulated according to tumor progression, it is a useful prognostic indicator. Detection of human telomerase reverse transcriptase (hTERT) mRNA or protein in various clinical samples is also applicable. However, careful attention should be paid to the false negative results due to the instability of this enzyme or hTERT mRNA and the existence of polymerase chain reaction inhibitors as well as the false-positive results due to the contamination by normal cells with telomerase activity. If these pitfalls are avoided, in situ detection of hTERT mRNA or protein will facilitate the reliability of telomerase as a tumor marker. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:221 / 233
页数:13
相关论文
共 120 条
  • [1] Telomerase activity in germ cell cancers and mature teratomas
    Albanell, J
    Bosl, GJ
    Reuter, VE
    Engelhardt, M
    Franco, S
    Moore, MAS
    Dmitrovsky, E
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (15) : 1321 - 1326
  • [2] Bièche I, 2000, CLIN CANCER RES, V6, P452
  • [3] Boldrini L, 2002, INT J ONCOL, V21, P493
  • [4] High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus
    Bonatz, G
    Frahm, SO
    Klapper, W
    Helfenstein, A
    Heidorn, K
    Jonat, W
    Krupp, G
    Parwaresch, R
    Rudolph, P
    [J]. HUMAN PATHOLOGY, 2001, 32 (06) : 605 - 614
  • [5] Telomerase activity and prognosis in primary breast cancers
    Carey, LA
    Kim, NW
    Goodman, S
    Marks, J
    Henderson, G
    Umbricht, CB
    Dome, JS
    Dooley, W
    Amshey, SR
    Sukumar, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3075 - 3081
  • [6] CHADENEAU C, 1995, CANCER RES, V55, P2533
  • [7] Chen XQ, 2000, CLIN CANCER RES, V6, P3823
  • [8] In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma
    Chou, SJ
    Chen, CM
    Harn, HJ
    Chen, CJ
    Liu, YC
    [J]. JOURNAL OF SURGICAL RESEARCH, 2001, 99 (01) : 75 - 83
  • [9] Telomerase activity and survival of patients with node-positive breast cancer
    Clark, GM
    Osborne, CK
    Levitt, D
    Wu, F
    Kim, NW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24) : 1874 - 1881
  • [10] Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA:: A simple blood test to monitor disease in cancer patients
    Dasí, F
    Lledó, S
    García-Granero, E
    Ripoll, R
    Marugán, M
    Tormo, M
    Garcia-Conde, J
    Aliño, SF
    [J]. LABORATORY INVESTIGATION, 2001, 81 (05) : 767 - 769